RESUMO
Animals tend to maintain a lower body weight for an extended period after leptin administration has ended. This may be due to an enhancement of metabolic rate that persists after treatment withdrawal. Our objectives were to determine the period of leptin influence, when injected intracerebroventricularly (icv), on food intake, body weight, and energy expenditure. Additionally, the relationship between expressions of UCP1, UCP2, and UCP3 in different adipose tissues and heat production (HP) was assessed. Twenty-four adult male Sprague-Dawley rats were injected intracerebroventricularly with either 10 g mouse leptin or 10 l vehicle once per day for 4 days. At 24 h after the last injection, one group was killed while the other was placed in calorimetry chambers and monitored for 21 days of recovery. Leptin-injected rats exhibited an overshoot of food intake and respiratory quotient (RQ) during recovery, but body weight remained significantly lower up to 6 days. HP decreased in both groups over time but remained higher in the leptin group through recovery. However, retained energy (RE) was significantly greater than control for about 8 days. Overall, UCP expression was reduced at the end of recovery in parallel with the decline in HP. Brown adipose tissue (BAT) was the most responsive to leptin administration by dramatically changing UCP1 and UCP3 mRNA levels. Our data show that leptin has extended effects on energy expenditure but relieves control on food intake and RQ after treatment withdrawal. This translated into a reduced positive energy balance that slowed body weight recovery.
Assuntos
Proteínas de Transporte/biossíntese , Metabolismo Energético/efeitos dos fármacos , Leptina/farmacologia , Proteínas de Membrana/biossíntese , Proteínas de Membrana Transportadoras , Proteínas Mitocondriais , Biossíntese de Proteínas , Animais , Peso Corporal/efeitos dos fármacos , Calorimetria Indireta , Primers do DNA , Ingestão de Alimentos/efeitos dos fármacos , Injeções Intraventriculares , Canais Iônicos , Leptina/administração & dosagem , Masculino , Consumo de Oxigênio/efeitos dos fármacos , RNA Mensageiro/biossíntese , Ratos , Ratos Sprague-Dawley , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Termogênese/efeitos dos fármacos , Proteína Desacopladora 1 , Proteína Desacopladora 2 , Proteína Desacopladora 3RESUMO
Better understanding of the mechanisms involved in adipose tissue growth and metabolism is critical for the development of more effective treatments for obesity. However, because of its high lipid and low protein content, adipose tissue can present unique problems in some experimental procedures. We describe three protocols that provide new or improved methods for analysis of DNA, RNA, and protein from different adipose tissues. The first protocol provides a simple and rapid method for separation of fragmented DNA and visualization of apoptotic DNA laddering without the need for radioisotopes. This technique allows for an estimate of the amount of DNA fragmentation, and hence, apoptosis. The second protocol details subcellular fractionation of adipose tissue for the extraction of protein in the mitochondrial and cytosol fractions and the measurement of apoptotic protein (Bcl-2 and Bax) levels in each fraction. The last protocol involves extraction of total RNA from adipose tissue and the measurement of uncoupling protein mRNA using real-time RT-PCR, a method that has not previously been used to measure expression of uncoupling proteins in adipose tissue.
Assuntos
Tecido Adiposo/patologia , Fragmentação do DNA , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Desacopladores/análise , Tecido Adiposo/metabolismo , Animais , Apoptose/fisiologia , Proteínas de Transporte/análise , Proteínas de Transporte/efeitos dos fármacos , Centrifugação , DNA/isolamento & purificação , Canais Iônicos , Leptina/efeitos adversos , Proteínas de Membrana/análise , Proteínas de Membrana/efeitos dos fármacos , Proteínas de Membrana Transportadoras/análise , Proteínas de Membrana Transportadoras/efeitos dos fármacos , Proteínas Mitocondriais/análise , Proteínas Mitocondriais/efeitos dos fármacos , Proteínas Proto-Oncogênicas/análise , Proteínas Proto-Oncogênicas c-bcl-2/análise , Ratos , Desacopladores/metabolismo , Proteína Desacopladora 1 , Proteína Desacopladora 2 , Proteína Desacopladora 3 , Proteína X Associada a bcl-2RESUMO
Oxidative cells increase mitochondrial mass in response to stimuli such as changes in energy demand or cellular differentiation. This plasticity enables the cell to adapt dynamically to achieve the necessary oxidative capacity. However, the pathways involved in triggering mitochondrial biogenesis are poorly defined. The present study examines the impact of altering energy provision on mitochondrial biogenesis in muscle cells. C2C12 myoblasts were chronically treated with supraphysiological levels of sodium pyruvate for 72 h. Treated cells exhibited increased mitochondrial protein expression, basal respiratory rate, and maximal oxidative capacity. The increase in mitochondrial biogenesis was independent of increases in peroxisomal proliferator activator receptor-gamma coactivator-1alpha (PGC-1alpha) and PGC-1beta mRNA expression. To further assess whether PGC-1alpha expression was necessary for pyruvate action, cells were infected with adenovirus containing shRNA for PGC-1alpha before treatment with pyruvate. Despite a 70% reduction in PGC-1alpha mRNA, the effect of pyruvate was preserved. Furthermore, pyruvate induced mitochondrial biogenesis in primary myoblasts from PGC-1alpha null mice. These data suggest that regulation of mitochondrial biogenesis by pyruvate in myoblasts is independent of PGC-1alpha, suggesting the existence of a novel energy-sensing pathway regulating oxidative capacity.
Assuntos
Metabolismo Energético , Mitocôndrias Musculares/metabolismo , Mioblastos Esqueléticos/metabolismo , Biossíntese de Proteínas , Ácido Pirúvico/metabolismo , Transativadores/metabolismo , Adaptação Fisiológica , Animais , Respiração Celular , Metabolismo Energético/efeitos dos fármacos , Expressão Gênica , Perfilação da Expressão Gênica , Camundongos , Camundongos Knockout , Mitocôndrias Musculares/efeitos dos fármacos , Tamanho Mitocondrial , Mioblastos Esqueléticos/efeitos dos fármacos , Análise de Sequência com Séries de Oligonucleotídeos , Oxirredução , Consumo de Oxigênio , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo , Biossíntese de Proteínas/efeitos dos fármacos , Ácido Pirúvico/farmacologia , Interferência de RNA , Transativadores/deficiência , Transativadores/genética , Fatores de TranscriçãoRESUMO
PGC-1alpha (peroxisome proliferator-activated receptor gamma coactivator 1alpha) is a master regulator of mitochondrial biogenesis and plays an important role in several other aspects of energy metabolism. To identify upstream regulators of PGC-1alpha gene transcription, 10,000 human full-length cDNAs were screened for induction of the PGC-1alpha promoter. A number of activators of PGC-1alpha transcription were found; the most potent activator was the transducer of regulated CREB (cAMP response element-binding protein) binding protein (TORC) 1, a coactivator of CREB. The other two members of the TORC family, TORC2 and TORC3, also strongly activated PGC-1alpha transcription. TORCs dramatically induced PGC-1alpha gene transcription through CREB. Forced expression of TORCs in primary muscle cells induced the endogenous mRNA of PGC-1alpha and its downstream target genes in the mitochondrial respiratory chain and TCA cycle. Importantly, these changes in gene expression resulted in increased mitochondrial oxidative capacity measured by cellular respiration and fatty acid oxidation. Finally, we demonstrated that the action of TORCs in promoting mitochondrial gene expression and function requires PGC-1alpha. Previous studies had indicated that TORCs function as a calcium- and cAMP-sensitive coincidence detector and mediate individual and synergistic effects of these two pathways. Our results, together with previous findings, strongly suggest that TORCs play a key role in linking these external signals to the transcriptional program of adaptive mitochondrial biogenesis by activating PGC-1alpha gene transcription.